FDA NDC Directory · JSON-LD · Markdown

Theophylline (Anhydrous)

NDC 69367-415 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Generic nameTheophylline Anhydrous
Labeler / ManufacturerWestminster Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA040560
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsTHEOPHYLLINE ANHYDROUS (600 mg/1)
Marketing started20251125
Package count1

External sources

Source: openFDA. Public-domain (CC0).